Sisthaema Seiquence is an injectable tissue stimulator intended for rebuilding the density, firmness and quality of facial skin. This medical device combines fragmented hyaluronic acid in a high concentration with a complex of nine amino acids, supporting the natural regeneration processes of the extracellular matrix.
Comprehensive support for the skin's biological rebuilding
The Sisthaema Seiquence formula was developed for skin showing reduced density, laxity and weakened supporting structures. The combination of fragmented hyaluronic acid (50 mg) with a full sequence of amino acids delivers the substrates needed for the synthesis of type I and type III collagen. As a result the device supports collagenogenesis and the qualitative rebuilding of the ECM at a structural level.
Biorevitalising and substrate action
Sisthaema Seiquence is a biorevitalising device that rebuilds through substrates and supports collagenogenesis. It is a complementary addition to hydrating protocols, offering a deep structural rebuilding of the tissues. It improves fibroblast metabolism, which translates into visible thickening of the skin, its lifting and a reduction of wrinkles caused by laxity.
Effects of use
Regular treatments with Sisthaema Seiquence deliver a clear improvement in skin density and elasticity. There is visible tissue lifting, improvement of the facial oval and a reduction of wrinkles linked to loss of firmness. The device works well in both corrective and preventive procedures.
Area of use
- face
